| Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective? | |
| | |
MedLine Citation:
|
PMID: 22259198 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Multi-organ resection in patients with non-urothelial cancer may include segmental ureteral resection. The resulting ureteral defect can be reconstructed with a transureteroureterostomy (TUU); however, whether TUU is safe and effective in this patient group remains unclear. OBJECTIVES: In the current retrospective analysis, we evaluated renal function before and after complex multi-organ resection that included TUU to determine whether TUU is safe and effective. METHODS: We retrospectively reviewed the charts of patients who underwent TUU between 1995 and 2011. Renal imaging studies performed before and after TUU were used to determine whether hydronephrosis was present in either kidney. Kidney function was assessed by measuring serum creatinine levels and calculating the estimated glomerular filtration rate (eGFR) before and after TUU. RESULTS: Twelve patients underwent TUU during multiorgan resection. Median follow-up time was 15 months. Three patients with cancer recurrence involving the TUU developed progressive hydronephrosis. Serum creatinine levels did not increase more than 0.5 mg/dl in any patient. Kidney function as assessed by eGFR was maintained in all patients (until the time of recurrence in the three patients with recurrence affecting the TUU). CONCLUSIONS: TUU during multi-organ resection for non-urothelial malignancy is safe and effective. Long-term renal function is maintained in the majority of patients. J. Surg. Oncol © 2012 Wiley Periodicals, Inc. |
| | |
Authors:
|
Phillip W Pisters; Curtis A Pettaway; Ping Liu; Surena F Matin; John F Ward; Dan Leibovici |
Related Documents
:
|
12122608 - Dipyridamole body surface potential mapping: noninvasive differentiation of syndrome x ... 11303698 - Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in ... 16966588 - Cost-effectiveness of coronary artery bypass grafts versus percutaneous coronary interv... 16484738 - Use of an air ambulance system improves time to treatment of patients with acute myocar... 22251408 - Efficacy and tolerability of intravenous paricalcitol in calcitriol-resistant hemodialy... 12123408 - Use of a clinical decision rule in combination with d-dimer concentration in diagnostic... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-18 |
Journal Detail:
|
Title: Journal of surgical oncology Volume: - ISSN: 1096-9098 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-19 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0222643 Medline TA: J Surg Oncol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 Wiley Periodicals, Inc. |
Affiliation:
|
Department of Urology, The University of Texas, MD Anderson Cancer Center, Houston, Texas. pisters@marshall.edu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular res...
Next Document: Molecular detection of Campylobacter jejuni as cause of culture-negative spondylodiscitis.